Cannara Biotech Reports Q2 2024 Financial Results
Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0 million in Q2 2023, a 77.2% increase.
- Gross profit, before fair value adjustments, increased to $7.1 million in Q2 2024 from $4.0 million in Q2 2023, a 77.2% increase.
- ft., today announced its fiscal second quarter 2024 financial and operating results for the three and six-month periods ended February 29, 2024.
- Gross cannabis revenues before excise taxes increased to $26.3 million in Q2 2024 from $15.9 million in Q2 2023, a $10.4 million or 65.4%, increase.
- The Company reports its financial results in accordance with International Financial Reporting Standards ("IFRS").